Yada Kanjanapan

Novel patterns of response under immunotherapy

Édith Borcoman, Yada Kanjanapan, Stéphane Champiat et al. · Annals of Oncology · 2019 · 491 citations · Full text

Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities

Yada Kanjanapan, Daphne Day, Lisa Wang et al. · Cancer · 2019 · 140 citations · Full text

Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials

Yada Kanjanapan, Daphne Day, Marcus O. Butler et al. · European Journal of Cancer · 2018 · 70 citations

Autoimmune Disease, Immunotoxicology, Adverse Event +9

Denosumab‐induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure

Nicholas Farinola, Yada Kanjanapan · Internal Medicine Journal · 2013 · 39 citations

Folic Acid Prevents and Partially Reverses Glucocorticoid-Induced Hypertension in the Rat

Y ZHANG, Pek Siew Lim, Yada Kanjanapan et al. · American Journal of Hypertension · 2007 · 34 citations · Full text